10. Common Stock Placements
In October 2010,
the Company commenced a private placement to sell common stock and warrants. For the year ended
December 31, 2011,
the Company sold 3,778,321 shares of Common Stock and issued 1,889,161 warrants and received cash proceeds of $3,730,587 net of $47,733 in offering costs. Under the terms of the offering, for each share purchased, the investor received one 5-year warrant to purchase the common stock of
the Company at an exercise price of $1.50 per share. The terms of the warrant, (the
"Callable Warrant") are that for every two shares of common stock purchased, the holder is issued a 5-year warrant to purchase one share of
the Company's Common Stock at an exercise price of $1.50 per share. The Callable Warrant was callable by
the Company at any time after the issuance if the closing sale price of the Stock exceeds $1.75 for fifteen (15) or more consecutive trading days. Upon written notice,
the Company may redeem the Callable Warrant at a price of $0.01 per share. In July 2012,
the Company decided to exercise its right to call approximately 3,345,000 warrants.
The Company raised approximately $4,900,000 and issued approximately 3,289,000 shares of MiMedx common stock including a total of 503,332 Callable Warrants exercised by
the Company's Chairman and CEO. The balance of 56,750 warrants were repurchased at $0.01 per share.
Additionally, under the terms of the offering
the Company issued a First Contingent Warrant (
"First Contingent Warrant") and a Second Contingent Warrant (
"Second Contingent Warrant") to Purchase Common Stock. These warrants vested assuming certain revenue targets were not achieved and could be voided if the closing trading price of
the Company's stock achieved a certain level for a specified number of consecutive trading days. The First Contingent Warrant vested during the second quarter of 2012 resulting in the issuance of approximately 1,673,000 warrants including approximately 252,000 to
the Company's Chairman and CEO, at an exercise price of $0.01 per share. On
July 3, 2012, 1,672,742 Second Contingent Warrants were voided which represented the tenth consecutive trading day of the closing trading price of
the Company stock being at least $1.75. As of
December 31, 2012 approximately 1,609,000 First Contingent Warrants have been exercised.